10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
44.45%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
44.45%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
44.46%
Net income growth above 1.5x OR's 26.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
44.44%
EPS growth above 1.5x OR's 21.43%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
44.44%
Diluted EPS growth above 1.5x OR's 21.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.03%
Share reduction more than 1.5x OR's 0.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.03%
Diluted share reduction more than 1.5x OR's 0.35%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-75.67%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-81.10%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.07%
10Y OCF/share CAGR under 50% of OR's 273.05%. Michael Burry would worry about a persistent underperformance in cash creation.
38.07%
Below 50% of OR's 192.29%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
85.35%
3Y OCF/share CAGR under 50% of OR's 22738.42%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-98.58%
Negative 10Y net income/share CAGR while OR is at 301.80%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-98.58%
Negative 5Y net income/share CAGR while OR is 117.59%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
88.82%
3Y net income/share CAGR similar to OR's 86.14%. Walter Schloss would attribute it to shared growth factors or demand patterns.
-34.68%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-34.68%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-34.20%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while OR shows 8.62%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.49%
Asset growth well under 50% of OR's 3.85%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.98%
Under 50% of OR's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.45%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.